Uploaded July 2025 | Updated September 2026, 2 weeks ago
Ari Siggaard Knoph from Novo Nordisk shares insights on how shifting workflows require balancing innovation with the need for trust among teams and stakeholders.
In the full episode, Ari explains how his company transitioned from SAS to R for FDA submissions, how Shiny apps played a key role in gaining internal buy-in, and how adopting open-source tools has improved productivity and attracted top talent. He also discusses the future of pharma technology and clinical programming.
Ari Siggaard Knoph from Novo Nordisk shares insights on how shifting workflows require balancing innovation with the need for trust among teams and stakeholders.
In the full episode, Ari explains how his company transitioned from SAS to R for FDA submissions, how Shiny apps played a key role in gaining internal buy-in, and how adopting open-source tools has improved productivity and attracted top talent. He also discusses the future of pharma technology and clinical programming.
